Lifen Xu

765 total citations
28 papers, 600 citations indexed

About

Lifen Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Lifen Xu has authored 28 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 5 papers in Immunology. Recurrent topics in Lifen Xu's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Lifen Xu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Lifen Xu collaborates with scholars based in Switzerland, United States and China. Lifen Xu's co-authors include Marijke Brink, Beat A. Kaufmann, Gabriela M. Kuster, Mark L. Trudell, Aaron Janowsky, John R. Cashman, Amanda Ochoa‐Espinosa, C Morandi, Laura Pentassuglia and Alexis Broisat and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Lifen Xu

28 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifen Xu Switzerland 15 250 161 77 72 72 28 600
Michael Gralinski United States 18 199 0.8× 343 2.1× 66 0.9× 99 1.4× 54 0.8× 32 709
Liguo Chi United States 16 422 1.7× 413 2.6× 27 0.4× 44 0.6× 50 0.7× 40 991
Daniel A. Richards United States 14 342 1.4× 267 1.7× 27 0.4× 89 1.2× 51 0.7× 21 773
Keiji Okuda Japan 11 213 0.9× 346 2.1× 27 0.4× 154 2.1× 26 0.4× 19 879
Yahan Liu China 12 373 1.5× 83 0.5× 113 1.5× 69 1.0× 19 0.3× 22 730
Cong Wei China 19 381 1.5× 224 1.4× 30 0.4× 44 0.6× 17 0.2× 47 784
Teresa Laragione Italy 6 300 1.2× 79 0.5× 38 0.5× 31 0.4× 23 0.3× 6 838
Barbara Kutryb-Zając Poland 15 277 1.1× 74 0.5× 27 0.4× 71 1.0× 31 0.4× 51 678
Bo Dong China 20 447 1.8× 522 3.2× 70 0.9× 146 2.0× 63 0.9× 50 1.2k

Countries citing papers authored by Lifen Xu

Since Specialization
Citations

This map shows the geographic impact of Lifen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifen Xu more than expected).

Fields of papers citing papers by Lifen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifen Xu. The network helps show where Lifen Xu may publish in the future.

Co-authorship network of co-authors of Lifen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lifen Xu. A scholar is included among the top collaborators of Lifen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifen Xu. Lifen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Juan, Lixin Shi, Miao Zhang, et al.. (2024). Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis. Acta Diabetologica. 61(8). 1053–1068. 3 indexed citations
2.
Bernasconi, Riccardo, et al.. (2023). The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice. APOPTOSIS. 29(3-4). 357–371. 6 indexed citations
3.
Schinner, Camilla, Lifen Xu, Henriette Franz, et al.. (2022). Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-αVβ6/TGF-β Signaling Cascade. Circulation. 146(21). 1610–1626. 28 indexed citations
4.
Xu, Lifen, Amanda Ochoa‐Espinosa, Sarah Decembrini, et al.. (2022). Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels. JACC Basic to Translational Science. 8(2). 189–200. 10 indexed citations
5.
Xu, Lifen, Emma Robinson, Beat A. Kaufmann, et al.. (2021). NOX1 mediates metabolic heart disease in mice and is upregulated in monocytes of humans with diastolic dysfunction. Cardiovascular Research. 118(14). 2973–2984. 15 indexed citations
6.
Ochoa‐Espinosa, Amanda, Lifen Xu, Jonas V. Schaefer, et al.. (2021). Designed Ankyrin Repeat Proteins as Novel Binders for Ultrasound Molecular Imaging. Ultrasound in Medicine & Biology. 47(9). 2664–2675. 1 indexed citations
7.
8.
Morandi, C, et al.. (2019). Neuregulin-1 triggers GLUT4 translocation and enhances glucose uptake independently of insulin receptor substrate and ErbB3 in neonatal rat cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(3). 118562–118562. 9 indexed citations
9.
Remy, Mélissa M., Lukas Flatz, Tommy Regen, et al.. (2017). Interferon-γ-Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever. Cell Host & Microbe. 22(3). 354–365.e5. 12 indexed citations
10.
Gaudiello, Emanuele, Ludovic Melly, Giulia Cerino, et al.. (2017). Scaffold Composition Determines the Angiogenic Outcome of Cell‐Based Vascular Endothelial Growth Factor Expression by Modulating Its Microenvironmental Distribution. Advanced Healthcare Materials. 6(24). 13 indexed citations
11.
Pentassuglia, Laura, et al.. (2016). Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes. American Journal of Physiology-Endocrinology and Metabolism. 310(9). E782–E794. 26 indexed citations
12.
Xu, Lifen & Marijke Brink. (2016). mTOR, cardiomyocytes and inflammation in cardiac hypertrophy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(7). 1894–1903. 93 indexed citations
13.
Shende, Pankaj, Lifen Xu, C Morandi, et al.. (2015). Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy. Cardiovascular Research. 109(1). 103–114. 51 indexed citations
14.
Xu, Lifen. (2014). The Process Research of Salidroside. 1 indexed citations
15.
Xu, Lifen. (2014). The Synthesis and Antifungal Activity of Cyclic Acetal Hydronopic Aldehyde Derivatives. Journal of Jiangxi Normal University. 1 indexed citations
16.
17.
Pfister, Otmar, Angelos Oikonomopoulos, Lifen Xu, et al.. (2013). FLT3 Activation Improves Post-Myocardial Infarction Remodeling Involving a Cytoprotective Effect on Cardiomyocytes. Journal of the American College of Cardiology. 63(10). 1011–1019. 29 indexed citations
18.
Xu, Lifen, et al.. (2012). Factors Affecting the Endothelial Retention of Targeted Microbubbles: Influence of Microbubble Shell Design and Cell Surface Projection of the Endothelial Target Molecule. Journal of the American Society of Echocardiography. 25(4). 460–466. 7 indexed citations
19.
Xu, Lifen, et al.. (1997). Synthesis, Dopamine Transporter Affinity, Dopamine Uptake Inhibition, and Locomotor Stimulant Activity of 2-Substituted 3β-Phenyltropane Derivatives. Journal of Medicinal Chemistry. 40(6). 858–863. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Gralinski Breakdown of academic impact, for papers by Liguo Chi Breakdown of academic impact, for papers by Daniel A. Richards Breakdown of academic impact, for papers by Keiji Okuda Breakdown of academic impact, for papers by Yahan Liu Breakdown of academic impact, for papers by Cong Wei Breakdown of academic impact, for papers by Teresa Laragione Breakdown of academic impact, for papers by Barbara Kutryb-Zając Breakdown of academic impact, for papers by Bo Dong
Rankless by CCL
2026